| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030237 | Ophthalmology | 2007 | 7 Pages |
Abstract
In this meta-analysis of clinical trials, the addition of dorzolamide or latanoprost further lowers IOP in eyes on timolol. This result may not be generalizable because these trials may have included nonresponders to timolol.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Carroll A.B. MD, PhD, Rikkert MSc, Jan S.A.G. MD, PhD, Maurice P. MSc, PhD, Martin H. MD, PhD, Fred MD, PhD,